Roche boosts laboratory workflow with cobas p 312 pre-analytical system
Rotkreuz/Switzerland, 02 April 2012
Entering into a new dimension of sample automation with space-saving solutions
Roche (SIX: RO, ROG; OTCQX: RHHBY) today inaugurates the new cobas p 312 fully-automated pre-analytical system, specifically designed for the improved workflow of small to mid-sized laboratories being faced with limited space preconditions. The computer controlled stand-alone solution with full online connectivity aids laboratory management to optimize laboratory’s workflow efficiency and hence cost and quality market position on no more than a square meter footprint.
Intelligent specimen handling and routing solutions for lab automation
Pre-analytics describe the process of efficient and seamless specimen preparation, routing and handling in the processes of automated laboratory systems. It helps to increase efficiency, minimize manual handling and offers accurate sample tracking throughout the whole process. For improved control, safety and service to clinicians, the cobas p 312 provides decapping, sorting and archiving of all common types of sample tubes within the laboratory´s serum work area (SWA), hematology, coagulation, and urinalysis. Health professionals reduce error prone manual routine processes and time consuming intervention of sample preparation while the potential of bio hazardous exposition decreases considerably.
Unique customized layout flexibility
The ergonomic workspace design allows a customized sample rack layout and management. This innovation in sample preparation and sorting offers maximum efficiency at minimal space requirements for highest flexibility at a lab´s workspace and a maximum throughput of up to 450 samples per hour.
Seamless online connectivity
Full online connectivity to the laboratory information system (LIS) allows laboratory managers to seamlessly integrate the cobas p 312 into the laboratory’s IT infrastructure. Its easy IT connectivity to the cobas® pre- and post-analytical systems family allows laboratories to flexibly integrate into a Total Laboratory Automation (TLA), including the full IT connectivity to Roche’s MODULAR® PRE-ANALYTICS EVO, when needed.
Simplified solutions from innovative minds
Based on Roche’s sensitivity to customer feedback the cobas p 312 exemplifies Roche’s tailored instrument and software solutions that fit into today’s laboratory infrastructure effectively. “As a first global product from Roche PVT, the cobas p 312 also marks a new milestone of demonstrating benefit from a pioneer in workflow automation collaborating with health professionals”, stated Colin Brown, Head of Roche Professional Diagnostics. As outcome highly benefits from the people involved, Roche further strengthens its pre- and postanalytics portfolio with Roche PVT’s most ambitious cross-team program, demonstrating a new dimension of high quality automation in the cobas product line.
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.
All trademarks used or mentioned in this release are protected by law.